Sravan Kumar Emany

Sravan Kumar Emany is a declared insider at 4 companies (finance chief); the most frequent names are Ironwood Pharmaceuticals Inc, Assertio Holdings, Inc. and Beam Therapeutics Inc. The record holds 20 filings, for trades running from 6 December 2021 to 16 June 2026.

On the open market, the record shows 2 purchases worth €375k and 3 sales worth €261k. Netting one side against the other leaves €113k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 13 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

The record was last updated on 16 June 2026 with a transaction in Assertio Holdings, Inc. The last purchase on record was published on 6 March 2024, which is 956 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.